ARCTOS MEDICAL
Arctos Medical is a spin-off company from the University of Bern and has developed a revolutionary gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.
ARCTOS MEDICAL
Founded:
2012-06-06
Address:
Bern, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.arctosmedical.com
Total Employee:
1+
Status:
Active
Total Funding:
8 M CHF
Technology used in webpage:
U.S. Server Location
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Oxford BioMedica
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Current Employees Featured
Kostas Kaloulis CEO @ Arctos Medical
CEO
Michiel van Wyk Co-founder @ Arctos Medical
Co-founder
Sonja Kleinlogel Co-founder @ Arctos Medical
Co-founder
Founder
Investors List
+ND Capital
+ND Capital investment in Seed Round - Arctos Medical
Novartis Venture Fund
Novartis Venture Fund investment in Seed Round - Arctos Medical
Official Site Inspections
http://www.arctosmedical.com
Unable to get host informations!!!
More informations about "Arctos Medical"
Home - Arcos
About Arcos We offer Health IT tools to give health care and blood bank professionals improved situational awareness for acute and critical care scenarios. BLOOD NAVIGATOR® Massive …See details»
About Arcos - Arcos
Co-founders George Kramer and Chris Meador teamed up in 2009 to develop Arcos, a company driven by the desire to develop and deliver easy-to-use clinical decision support tools for …See details»
Arctos Medical - Crunchbase Company Profile & Funding
Organization. Arctos Medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Arctos Medical is a developed gene therapy that does not correct rare genetic eye diseases …See details»
Arctos Medical - Ownership and Business Overview - Mergr
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021.The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was …See details»
Arctos’s Competitors, Revenue, Number of Employees, Funding
Arctos’s Profile, Revenue and Employees. Arctos is a Switzerland-based biotechnology company that researches and develops optogenetic therapies for the treatment of blindness.See details»
arctosmedical.com
Arctosmedical.comSee details»
Arcos - Crunchbase Company Profile & Funding
Arcos provides clinical decision support tools to empower health care workers.See details»
Arctos Medical AG - startupticker.ch
Sep 21, 2021 Arctos Medical is a spin-off company from the University of Bern and has developed a revolutionary gene therapy that does not correct rare genetic eye diseases but …See details»
Arctos Medical - PitchBook
Arctos Medical General Information Description. Developer of optogenetic therapies designed to treat blind people. The company specializes in developing optogenetic therapies to treat genetic diseases called inherited retinal …See details»
Home - Arcos
About Arcos We offer Health IT Support tools to empower health care workers in targeted critical care situations, improving patient outcomes and reducing health care costs. BLOOD …See details»
Arcos Company Profile - Office Locations, Competitors, Revenue
Arcos is a company that develops and provides clinical decision support tools. It offers Burn Navigator, a tool that guides and monitors IV fluid therapy for adult and pediatric severe burn …See details»
ARCTOS Medical is Acquired by Novartis - LinkedIn
Sep 26, 2021 The Arctos Medical team is thrilled that Novartis recognized the potential value and differentiated profile of our unique optogenetics technology. Novartis is ideally positioned …See details»
Arctos Medical AG Asset Profile - Preqin
Based in Bern, Switzerland, and founded in 2012 Arctos Medical AG provides optogenetic programs and gene therapy solutions for the treatment of rare genetic ...See details»
Arctos Medical - Products, Competitors, Financials, Employees ...
Arctos Medical conducts preclinical work on a vector-delivered technology to restore eyesight in patients whose retinal cells have degenerated, rather than those whose blindness is caused …See details»
Arcos Company Profile -Sales, Contacts, Competitors – Buzzfile
Www.arcosmedical.com: Arcos, Inc. is the only company located at 4714 RIVERSTONE BLVD, Missouri City, TX 77459. Map View larger map Directions. ... This organization has been …See details»
Arctos Medical - Ownership and Business Overview - Mergr
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021.The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was …See details»
Arcos, Inc. - isbt128.org
Chris.meador@arcosmedical.com. Categories: uncategorized, software vendor. Regions: Regions not available. Description: Description not available. NAVIGATE: ISBT 128 Basics. …See details»
Blood Navigator - Arcos
The Blood Navigator system includes: Blood Navigator tablet with software, barcode scanner, IV pole bracket and accessories for easy attachment to rapid infuser poles, anesthesia machine …See details»
Arctos Medical - VentureRadar
Website: http://www.arctosmedical.com/ Arctos Medical is a spin-off company from the University of Bern, developing viral vector technology for the restoration of ...See details»
Robotic patient transfer device launches at Ottawa hospital
5 hours ago Bruyère Health was the first organization to start using the ALTA Platform. Doering said she quickly saw its value for the health and time of health-care workers, as well as for …See details»